Wilmington Savings Fund Society’s GeneDx Holdings WGS Stock Holding History

Wilmington Savings Fund Society’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-200	Closed	-$12.8K	–	1557
2026 Q1	$12.8K	Hold	200	–	–	﹤0.01%	1152
2025 Q4	$26K	Hold	200	–	–	﹤0.01%	1015
2025 Q3	$21.5K	Hold	200	–	–	﹤0.01%	1064
2025 Q2	$18.5K	Hold	200	–	–	﹤0.01%	1495
2025 Q1	$17.7K	Buy	+200	New	+$17.4K	﹤0.01%	1493

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Wilmington Savings Fund Society's WGS Position: Q2 2026 in Review

Wilmington Savings Fund Society sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 200 shares — an estimated $12.8K sold.

Wilmington Savings Fund Society first reported a position in WGS in Q1 2025 and held it in 5 quarters. The position peaked at $26K in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Wilmington Savings Fund Society reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
Wilmington Savings Fund Society sold 200 GeneDx Holdings shares in Q2 2026, an estimated $12.8K.
Wilmington Savings Fund Society first reported a position in GeneDx Holdings in Q1 2025 and held it in 5 quarters.
Wilmington Savings Fund Society's GeneDx Holdings position peaked at $26K in Q4 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.